Dr. John Sim, MD

NPI: 1255490868
Total Payments
$19,596
2023 Payments
$486.49
Companies
5
Transactions
10

Payment Breakdown by Category

Consulting$19,000 (97.0%)
Food & Beverage$358.41 (1.8%)
Travel$237.64 (1.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $19,000 2 97.0%
Food and Beverage $358.41 7 1.8%
Travel and Lodging $237.64 1 1.2%

Top Paying Companies

Company Total Records Latest Year
Mallinckrodt LLC $19,000 2 $0 (2018)
Alexion Pharmaceuticals, Inc. $516.82 4 $0 (2023)
Allergan Inc. $48.10 2 $0 (2018)
Novartis Pharmaceuticals Corporation $15.74 1 $0 (2018)
Relypsa, Inc. $15.39 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $486.49 3 Alexion Pharmaceuticals, Inc. ($486.49)
2022 $30.33 1 Alexion Pharmaceuticals, Inc. ($30.33)
2018 $19,064 5 Mallinckrodt LLC ($19,000)
2017 $15.39 1 Relypsa, Inc. ($15.39)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/10/2023 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Travel and Lodging In-kind items and services $237.64 General
Category: Rare Disease
03/10/2023 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $127.60 General
Category: Rare Disease
03/10/2023 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $121.25 General
Category: Rare Disease
04/25/2022 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $30.33 General
Category: Rare Disease
05/11/2018 Mallinckrodt LLC ACTHAR (Biological) Consulting Fee Cash or cash equivalent $7,125.00 General
Category: AUTOIMMUNE AND RARE DISEASE
04/26/2018 Allergan Inc. BYSTOLIC (Drug) Food and Beverage In-kind items and services $23.89 General
Category: CARDIOVASCULAR
03/12/2018 Allergan Inc. BYSTOLIC (Drug) Food and Beverage In-kind items and services $24.21 General
Category: CARDIOVASCULAR
02/20/2018 Mallinckrodt LLC ACTHAR (Biological) Consulting Fee Cash or cash equivalent $11,875.00 General
Category: AUTOIMMUNE AND RARE DISEASE
02/12/2018 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $15.74 General
Category: CARDIOVASCULAR
02/06/2017 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $15.39 General
Category: Hyperkalemia

About Dr. John Sim, MD

Dr. John Sim, MD is a Nephrology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255490868.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Sim, MD has received a total of $19,596 in payments from pharmaceutical and medical device companies, with $486.49 received in 2023. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($19,000).

Practice Information

  • Specialty Nephrology
  • Location Los Angeles, CA
  • Active Since 12/08/2006
  • Last Updated 11/29/2021
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1255490868

Products in Payments

  • ACTHAR (Biological) $19,000
  • ULTOMIRIS (Biological) $516.82
  • BYSTOLIC (Drug) $48.10
  • ENTRESTO (Drug) $15.74
  • Veltassa (Drug) $15.39

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Los Angeles